Product Name :
Inhibitor of Thrombospondin (TSP-1) (TFA)
CAS NO. :
162559-45-7
Formula :
C21H41N5O6
Molecular Weight::
459.58
Target:
TGF-beta/Smad
Serial Number:
Leu-Ser-Lys-Leu
Short serial number :
LSKL
Purity:
95%
Description :
LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier.
References:
[1].Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model. [2]. In silico characterization of the interaction between LSKL peptide, a LAP-TGF-beta derived peptide, and ADAMTS1. [3].LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-β1 signaling activity following subarachnoid hemorrhage in rats.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NF-KB p65 Antibody
eIF4EBP1 Antibody
MMP1 Antibody: MMP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,IP assays with tag free, in the background of Human.